Archive for March, 2008

Free Weight Loss Patch Helps You Lose Weight – Can You Believe It?

If you are googling for “free weight loss patch” then you must be searching for a way to lose weight by using weight loss patches that offer free trial.

This means that you do not pay for the patches (they are totally free) but you must pay as little as a couple of bucks for shipping. You will probably use the weight loss patches for one week (usually that’s how long free trials last); you will see the promising results (curbed appetite, more energy, etc.) and will return for reorder of a full pack (usually for one to six months).

At least that’s the way it works for most of our customers who have tried the one week free trial of Hoodia Weight Loss Patch. If you wanna give it a try, you can do it immediately at Hoodia Free Weight Loss Patch official website.

GSK - Seroxat/Paxil: happy retirement JPG


A fitting fare thee well!Sphere: Related Content

Rx - sex and drugs and quarterly goals, Part 6


Rob meets Officer Williams.
Enjoy!Sphere: Related Content

GSK - Seroxat/Paxil: MHRA toughen up the law

Britain is to strengthen the law on disclosing drug trial results following a four-year inquiry into GlaxoSmithKline's delay in reporting data linking its antidepressant Seroxat to suicide risk in teenagers.

"We will take immediate steps to ensure the law is strengthened further, so that there can be no doubt as to companies' obligations to report safety issues," Kent Woods, chief executive of the Medicines and Healthcare products Regulatory Agency (MHRA), said in a statement on Thursday.

The watchdog advised doctors in 2003 not to give Seroxat to patients under the age of 18, after Glaxo handed over data showing it could increase their risk of suicidal behaviour.

An investigation with a view to potential criminal prosecution was launched due to concerns that Europe's biggest drugmaker had held the information for some time before this and failed to disclose it.

But GSK have avoided prosecution.

More from Ben Hirschler at Reuters

MHRA documents.

Sphere: Related Content

Lilly - Viva Zyprexa: North to Alaska

Michelle Shocked.

Jury selection for one of the biggest civil trials ever in Alaska is now under way in Anchorage Superior Court with attorneys from around the country, an instant Internet feed for those willing to pay big bucks, and tens of millions of dollars riding on the verdict.

At issue is Zyprexa, pharmaceutical giant Eli Lilly & Co.'s best-selling drug. It is approved for treatment of schizophrenia and bipolar disorder.

The state of Alaska sued Eli Lilly in 2006, alleging the company failed to warn of serious health risks for people who take Zyprexa, including the risk of diabetes. It wants the company to cover treatment costs of Medicaid patients who suffered serious health problems after being on the drug.

But Eli Lilly says the state has two irreconcilable positions -- at the same time the state is suing the company, it continues seeking court orders to force mental patients to take the very drug it says is so harmful. Zyprexa has been prescribed for more than 23 million people since its initial approval in 1996, according to Lilly, and it still is being prescribed in the United States and more than 80 other countries. Global sales of Zyprexa last year topped $4.8 billion.

Eight other states have suits pending, plus another 1,200 suits by private individuals are awaiting trial. Alaska's is the first to make it to a jury so all eyes are on Judge Mark Rindner's fourth floor courtroom.

More

In addition, a federal criminal investigation is being conducted in Pennsylvania.

Sphere: Related Content